| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |